About us
Based in Mexico, aevus delivers high quality and low cost active pharmaceutical ingredients (API’s) for the production of specialized biologic drugs, including biosimilars and innovator drugs. We partner in the same way with API manufacturers and API customers across the globe, with the base idea that their success is directly related to our own.
For our manufacturing partners, we support their growth by helping them reach new and attractive markets. And for our customer partners, we help them consolidate and grow their drug product portfolio and pipeline, with a constant approval of products. At aevus, our must important goal is to expedite and guide the best partnerships between biopharma organizations for the development, manufacturing and supply of products. To achieve this, we provide an integrated service.
About us
Based in Mexico, aevus delivers high quality and low cost active pharmaceutical ingredients (API’s) for the production of specialized biologic drugs, including biosimilars and innovator drugs. We partner in the same way with API manufacturers and API customers across the globe, with the base idea that their success is directly related to our own.
For our manufacturing partners, we support their growth by helping them reach new and attractive markets. And for our customer partners, we help them consolidate and grow their drug product portfolio and pipeline, with a constant approval of products. At aevus, our must important goal is to expedite and guide the best partnerships between biopharma organizations for the development, manufacturing and supply of products. To achieve this, we provide an integrated service.
Solutions
customers
Are you looking for a centralized source of an API?
We can offer you solutions with our current manufacturing network or create a brand new supply channel. We have various services to support your drug product development project.
manufacturing partners
Join us to get your product to new attractive markets and expand your customer portfolio.
Our costumer partners are key market players with a good record of product approvals. We have particular understanding of the Latin-American market where we are located.
News
Genentech Files Complaint Over Amgen’s Development of Avastin Biosimilar
Genentech Files Complaint Over Amgen’s Development of Avastin ...
Read moreCelltrion’s Rituximab Biosimilar Truxima Approved in Europe
Celltrion’s Rituximab Biosimilar Truxima Approved in ...
Read moreBiocon, Mylan allowed to sell 3 cancer biosimilars
Biocon, Mylan allowed to sell 3 cancer biosimilars Mumbai, ...
Read moreUK court delivers high-stakes decision on world’s best-selling drug
UK court delivers high-stakes decision on world’s ...
Read moreBiosimilars: The Pipeline Seams Seem To Be Bursting
Hundreds of products are at some stage of development, but only ...
Read moreLooking for a particular service or want to partner up?
Our commercial team is ready to assist you. We want to discuss your requirements and we can support you with our solutions portfolio.